74 related articles for article (PubMed ID: 24836709)
1. Glutamic acid decarboxylase (GAD) antibodies in epilepsy: diagnostic yield and therapeutic implications.
Lilleker JB; Biswas V; Mohanraj R
Seizure; 2014 Sep; 23(8):598-602. PubMed ID: 24836709
[TBL] [Abstract][Full Text] [Related]
2. Temporal lobe epilepsy with GAD antibodies: neurons killed by T cells not by complement membrane attack complex.
Tröscher AR; Mair KM; Verdú de Juan L; Köck U; Steinmaurer A; Baier H; Becker A; Blümcke I; Finzel M; Geis C; Höftberger R; Mawrin C; von Oertzen TJ; Pitsch J; Surges R; Voges B; Weis S; Winklehner M; Woermann F; Bauer J; Bien CG
Brain; 2023 Apr; 146(4):1436-1452. PubMed ID: 36314080
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune epilepsy: clinical characteristics and response to immunotherapy.
Quek AM; Britton JW; McKeon A; So E; Lennon VA; Shin C; Klein C; Watson RE; Kotsenas AL; Lagerlund TD; Cascino GD; Worrell GA; Wirrell EC; Nickels KC; Aksamit AJ; Noe KH; Pittock SJ
Arch Neurol; 2012 May; 69(5):582-93. PubMed ID: 22451162
[TBL] [Abstract][Full Text] [Related]
4. Electroencephalographic abnormalities in children with type 1 diabetes mellitus: a prospective study.
Yildirim R; Günbey C
Turk J Med Sci; 2023; 53(6):1794-1798. PubMed ID: 38813513
[TBL] [Abstract][Full Text] [Related]
5. Neurological autoantibody prevalence in chronic epilepsy: Clinical and neuropathologic findings.
Zhou K; Zhang L; Shen S; Lin JF; Wang JR; Zhou D; Li JM; Sima X
Seizure; 2024 Feb; 115():28-35. PubMed ID: 38183825
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune epilepsy, retrospective case series of clinical features, management, and outcomes.
Khan AA; Alzahrani WM; Bagadood RM; Alweshah BM; Alsulaimi JF; Abualela HM
Neurosciences (Riyadh); 2023 Oct; 28(4):264-269. PubMed ID: 37844942
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune musicogenic epilepsy associated with anti-glutamic acid decarboxylase antibodies and Stiff-person syndrome.
Jesus-Ribeiro J; Bozorgi A; Alkhaldi M; Shaqfeh M; Fernandez-Baca Vaca G; Katirji B
Clin Case Rep; 2020 Jan; 8(1):61-64. PubMed ID: 31998487
[TBL] [Abstract][Full Text] [Related]
8. Treatment of immune-mediated temporal lobe epilepsy with GAD antibodies.
Malter MP; Frisch C; Zeitler H; Surges R; Urbach H; Helmstaedter C; Elger CE; Bien CG
Seizure; 2015 Aug; 30():57-63. PubMed ID: 26216686
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic plasma exchange and immunosuppressive therapy in a patient with anti-GAD antibody-related epilepsy: quantification of the antibody response.
Farooqi MS; Lai Y; Lancaster E; Schmitt SE; Sachais BS
J Clin Apher; 2015 Feb; 30(1):8-14. PubMed ID: 24961613
[TBL] [Abstract][Full Text] [Related]
10. Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy.
Daif A; Lukas RV; Issa NP; Javed A; VanHaerents S; Reder AT; Tao JX; Warnke P; Rose S; Towle VL; Wu S
Epilepsy Behav; 2018 Mar; 80():331-336. PubMed ID: 29433947
[TBL] [Abstract][Full Text] [Related]
11. A clinical approach to diagnosis of autoimmune encephalitis.
Graus F; Titulaer MJ; Balu R; Benseler S; Bien CG; Cellucci T; Cortese I; Dale RC; Gelfand JM; Geschwind M; Glaser CA; Honnorat J; Höftberger R; Iizuka T; Irani SR; Lancaster E; Leypoldt F; Prüss H; Rae-Grant A; Reindl M; Rosenfeld MR; Rostásy K; Saiz A; Venkatesan A; Vincent A; Wandinger KP; Waters P; Dalmau J
Lancet Neurol; 2016 Apr; 15(4):391-404. PubMed ID: 26906964
[TBL] [Abstract][Full Text] [Related]
12. The neurological syndromes associated with glutamic acid decarboxylase antibodies.
Baizabal-Carvallo JF
J Autoimmun; 2019 Jul; 101():35-47. PubMed ID: 31000408
[TBL] [Abstract][Full Text] [Related]
13. Refractory status epilepticus and glutamic acid decarboxylase antibodies in adults: presentation, treatment and outcomes.
Khawaja AM; Vines BL; Miller DW; Szaflarski JP; Amara AW
Epileptic Disord; 2016 Mar; 18(1):34-43. PubMed ID: 26878120
[TBL] [Abstract][Full Text] [Related]
14. Clinical Management of Epilepsy With Glutamic Acid Decarboxylase Antibody Positivity: The Interplay Between Immunotherapy and Anti-epileptic Drugs.
Mäkelä KM; Hietaharju A; Brander A; Peltola J
Front Neurol; 2018; 9():579. PubMed ID: 30057567
[No Abstract] [Full Text] [Related]
15. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
[TBL] [Abstract][Full Text] [Related]
16. GAD65 Antibody-Associated Epilepsy.
Valinčiūtė J; Jucevičiūtė N; Balnytė R; Jurkevičienė G; Gelžinienė G
Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374339
[TBL] [Abstract][Full Text] [Related]
17. Favorable response to classic ketogenic diet in a child with anti-GAD 65 antibody mediated super refractory status epilepticus.
Sivathanu D; Kewalramani D; Kumar Manokaran R
Epilepsy Behav Rep; 2022; 19():100557. PubMed ID: 35789965
[TBL] [Abstract][Full Text] [Related]
18. Immunity, Ion Channels and Epilepsy.
Chen TS; Lai MC; Huang HI; Wu SN; Huang CW
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742889
[TBL] [Abstract][Full Text] [Related]
19. Musicogenic reflex seizure with positive antiglutamic decarboxylase antibody: A case report.
Al-Attas AA; Al Anazi RF; Swailem SK
Epilepsia Open; 2021 Sep; 6(3):607-610. PubMed ID: 34218519
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
